A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...

U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...

This year’s honorees aren’t inheriting the financial system. They’re building the infrastructure for what comes next.

The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...

With Trump floating tariffs on medicine, suppliers are weighing upgrades, relocation, and, for some, the exit.

The much-publicized introduction of genetically modified cubs that share features of extinct dire wolves sparked claims ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...